Latest news
FDA clears Healis Therapeutics’ IND for Tyemvers®, Enabling U.S. Neuropsychiatric Trials - FinancialContentFinancialContent · Tue, 04 Aug 2026 12:00:00 GMTCKD BiO wins FDA nod, starts US trial of botulinum toxin for depression - CHOSUNBIZ - ChosunbizChosunbiz · Thu, 30 Jul 2026 07:00:00 GMTBotulinum Toxin Wins First FDA Clearance to Test Frown-Muscle Theory of Depression - Tech TimesTech Times · Thu, 30 Jul 2026 07:00:00 GMT